Quality Management System Compliance
Quality system maturity, design control integrity, and audit readiness determine FDA and ISO success
Key Outcomes
A structured quality system aligned with FDA and ISO requirements
Operational systems for document control, CAPA, and supplier oversight
Fully traceable design controls supporting regulatory submissions
Inspection-ready quality documentation for FDA and ISO audits
A complete quality management system is required for medical device companies entering the U.S. market. FDA expects a coherent, traceable, and consistently maintained system that integrates design controls, verification and validation, document management, supplier oversight, complaint handling, and risk-based decision making. Emerging and international manufacturers frequently encounter delays because their documentation does not meet FDA quality system regulation or ISO 13485 expectations.
UnifiMed builds, evaluates, and remediates quality systems that support regulatory submissions, inspection readiness, and long-term commercial scalability.
CHALLENGES
Where QMS Gaps Create Regulatory and Audit Exposure
Across emerging and scaling MedTech organizations, recurring quality system deficiencies create preventable regulatory risk
Incomplete design controls or poor alignment between user needs, design inputs, and outputs
Fragmented technical documentation lacking traceability across verification and validation activities
Risk management practices that do not demonstrate effective risk controls or ISO 14971 alignment
Limited or underdeveloped supplier quality management and supplier audit programs
Ineffective complaint handling, CAPA, or nonconformance management workflows
Weak or inconsistent document control processes
These gaps undermine compliance, increase audit exposure, and slow US market entry
OUR PROCESS
How We Align Quality Management System Compliance
UnifiMed develops a complete QMS compliance framework aligned with regulatory, operational, and commercial requirements
QMS Gap Assessment and Compliance Roadmap
We evaluate the entire quality system against FDA QSR and ISO 13485 expectations by reviewing system-level subsystems, controlled documents, organizational responsibilities, DHF and technical documentation structure, and all associated quality records. We then develop a prioritized remediation roadmap that sequences required updates and establishes the foundation for a modernized, inspection-ready QMS
Design Controls and Technical Documentation
We align design controls with regulatory and audit requirements by reviewing design inputs, outputs, verification, and validation, mapping design controls to testing requirements, integrating revision history into the DHF, assessing usability and labeling evidence, and coordinating technical documentation remediation. This ensures design files remain fully traceable and withstand FDA or ISO audit review
Risk Management and Technical File Alignment
We strengthen risk documentation by evaluating hazard analysis, residual risk rationale, and risk control implementation, mapping controls to design features and supporting test evidence, integrating all risk documentation into the technical file, and aligning practices with ISO 14971 and FDA expectations. This creates a defensible, risk-based foundation for regulatory submission
Quality System Operations & Audit Readiness
We strengthen core quality system operations by optimizing document control, supplier quality management, CAPA and complaint workflows, and training documentation. We conduct internal audits and mock inspections to verify traceability, documentation completeness, and audit readiness, ensuring the QMS reliably supports regulatory submissions and sustained compliance
Ready to Learn More?
Contact our team to discuss how we can support your Quality Management System needs